Arlington, MA, United States of America

Rosemary O'Connor

This inventor holds 2 USPTO granted patents. Top assignees: Apoptosis Technology, Inc., Thomas Jefferson University, Other. Active years: 1999-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rosemary O'Connor. Retrieved from https://idiyas.com/inventor/rosemary-o-connor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1999-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Rosemary O'Connor: Innovator in Apoptosis Research**

Introduction

Rosemary O'Connor, hailing from Arlington, MA, is an accomplished inventor recognized for her significant contributions to the field of apoptosis research. Her work focuses on the Insulin-like Growth Factor-I Receptor (IGF-IR), which is crucial for understanding cell survival mechanisms in vertebrates. With two patents to her name, O'Connor's innovative approaches have paved the way for advancements in therapeutic applications.

Latest Patents

O'Connor's latest patents revolve around the active survival domains of IGF-IR and their methods of use. Her research has identified the essential components required for transmitting survival signals in vertebrate cells. In particular, she found that IGF-I protects cells from apoptosis under specific conditions, mimicking the protective effects offered by Bcl-2 expression. Moreover, her investigations revealed that certain mutations within the IGF-I receptor's tyrosine cluster retain survival functions, while others, particularly at the C-terminus, enhance anti-apoptotic capabilities. This groundbreaking work is vital for developing new methods to modulate apoptosis in vertebrate cells.

Career Highlights

Throughout her career, O'Connor has made notable strides in her field. By working at Apoptosis Technology, Inc. and Thomas Jefferson University, she has been able to conduct pioneering research and develop her patented methodologies. Her dedication to advancing apoptosis-related studies exemplifies her commitment to scientific innovation.

Collaborations

One of her significant collaborations has been with Renato L. Baserga, a fellow researcher in the field. Together, they have contributed to the understanding of IGF-IR and its implications in cellular survival mechanisms, fostering a collaborative spirit vital for scientific progress.

Conclusion

In summary, Rosemary O'Connor stands out as an influential inventor whose work on the Insulin-like Growth Factor-I Receptor has broad implications for apoptosis research and potential therapeutic applications. Her innovative findings and collaborations underline the importance of her contributions in advancing the understanding of cell survival and death mechanisms.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…